コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n of new vaccines and drugs for this leading parasitic disease.
2 er bacterial growth nor microscopic signs of parasitic disease.
3 chronic infections, such as tuberculosis or parasitic disease.
4 alaria is a life-threatening and devastating parasitic disease.
5 ease classification of this highly neglected parasitic disease.
6 ene manipulation in combating this important parasitic disease.
7 is (VL), the second most deadly vector-borne parasitic disease.
8 mber of infections and deaths caused by this parasitic disease.
9 , 22.0% had bacterial disease, and 10.9% had parasitic disease.
10 tor, against visceral leishmaniasis, a fatal parasitic disease.
11 ant virulence factors in the pathogenesis of parasitic disease.
12 tter way of accounting for the true costs of parasitic disease.
13 tability of susceptibility to this important parasitic disease.
14 the role of environmental factors for other parasitic diseases.
15 cluding early-onset blindness, diabetes, and parasitic diseases.
16 mous therapeutic benefits for the control of parasitic diseases.
17 ntimate contact with T cells in allergic and parasitic diseases.
18 ca, is the third leading cause of death from parasitic diseases.
19 ical animal models for viral, bacterial, and parasitic diseases.
20 ing new therapeutic agents effective against parasitic diseases.
21 oses and erroneous descriptions of new human parasitic diseases.
22 ependent interventions against parasites and parasitic diseases.
23 t of several diseases, including cancers and parasitic diseases.
24 heir extensive application in autoimmune and parasitic diseases.
25 e urgently needed for neglected vector-borne parasitic diseases.
26 individual and public health effect of these parasitic diseases.
27 ass of drugs for the therapy of vector-borne parasitic diseases.
28 inical candidates for the treatment of other parasitic diseases.
29 obstacle to controlling and eliminating many parasitic diseases.
30 n the treatment of river blindness and other parasitic diseases.
31 diversity, and drug targets against multiple parasitic diseases.
32 applied in the diagnosis of other infectious-parasitic diseases.
33 14.9 million) were the most common foodborne parasitic diseases.
34 ura and Tu have transformed the treatment of parasitic diseases.
35 rapy for patients suffering from devastating parasitic diseases.
36 a variety of infectious diseases, especially parasitic diseases.
37 s; and 3,115 (9%) were due to infectious and parasitic diseases.
38 eatment of cancer, AIDS, cardiovascular, and parasitic diseases.
39 ms and also for the treatment of devastating parasitic diseases.
40 a novel treatment for a variety of neglected parasitic diseases.
41 Respiratory Syndrome coronavirus and several parasitic diseases.
42 eatment of toxoplasmosis and perhaps related parasitic diseases.
43 -dose in vivo data in three rodent models of parasitic diseases.
44 uctural biology to benefit the fight against parasitic diseases.
45 ite relationship, and in the pathogenesis of parasitic diseases.
46 eral leishmaniasis and malaria-two important parasitic diseases.
47 cancer chemotherapy and for the treatment of parasitic diseases.
48 ing the cyclone for injuries, infectious and parasitic diseases (1.8% [95% CrI, 0.1%-3.6%]; 0.2 [95%
49 with increased mortality from infectious and parasitic diseases (4.1; 95% CI, 1.7-8.5), septicemia (6
50 e interval [CI]: 10.9-17.9%); infectious and parasitic diseases (4.3%; 95%CI: 1.2-8.1%); and injuries
58 tosomiasis is among the most prevalent human parasitic diseases, affecting more than 200 million peop
60 ere is no licensed vaccine against any human parasitic disease and apicomplexan parasites cause enorm
62 ics to understand the biology and control of parasitic disease and present a practical framework for
63 nce of immunoendocrine interactions during a parasitic disease and show a possible new mechanism of p
64 the progression and pathology of congenital parasitic diseases and identifying future research direc
67 immune cells with central roles in allergy, parasitic diseases and multiple inflammatory conditions.
68 aluating eosinophilia in patients at risk of parasitic diseases and present a simple algorithm to gui
69 of training and practice in the diagnosis of parasitic diseases and that efforts should be made to tr
70 ntics are used to treat human and veterinary parasitic diseases and to reduce crop and livestock prod
71 trient intake may increase susceptibility to parasitic diseases and together they negatively affect c
72 .26 (95% CI, 23.85-33.48) for infectious and parasitic diseases, and 57.11 (95% CI, 45.23-72.11) for
73 ry diseases, 152 (34.2%) from infectious and parasitic diseases, and 82 (18.5%) from nervous system d
74 ug administrations for controlling neglected parasitic diseases, and can be lethal to malaria vectors
75 in the pathogenesis of asthma, allergic and parasitic diseases, and hypereosinophilic syndromes, in
78 al infection, but other bacterial, viral and parasitic diseases are receiving increasing attention.
80 onmental effects on the transmission of many parasitic diseases are well recognized, but the role of
81 al leishmaniasis (VL) is a potentially fatal parasitic disease associated with fever, cachexia and im
86 etabolic targets to combat tumors, virus and parasitic diseases but have not yet been studied in Phyt
87 Visceral leishmaniasis is a life-threatening parasitic disease, but current antileishmanial drugs hav
88 tribute to T cell activation in allergic and parasitic diseases by presenting superantigens and pepti
89 of death, including injuries, infectious and parasitic diseases, cardiovascular diseases, neuropsychi
93 play key roles in mechanisms associated with parasitic disease caused by the apicomplexan parasites P
95 Human schistosomiasis--or bilharzia--is a parasitic disease caused by trematode flukes of the genu
98 get for the chemotherapy of several tropical parasitic diseases caused by trypanosomes and leishmania
100 Visceral leishmaniasis (VL) is a serious parasitic disease, causing high morbidity and mortality
101 e treatment for cryptosporidiosis; and these parasitic diseases continued to have a worldwide impact
107 cells, whereas macrophages in neoplastic and parasitic diseases express anti-inflammatory cytokines t
108 Amebic colitis is an important worldwide parasitic disease for which there is not a well-establis
109 The leishmaniases are globally important parasitic diseases for which no human vaccines are curre
113 istance and increasing exposure to viral and parasitic diseases has spurred renewed interest into dru
114 ase and none with hepatolithiasis or biliary parasitic disease; however, heavy tobacco use (27%) and
116 Toxoplasmosis, while often an asymptomatic parasitic disease in healthy individuals, can cause seve
119 ican trypanosomiasis (gHAT), a vector-borne, parasitic disease in West and Central Africa, by 2030.
123 Schistosomiasis is among the most common parasitic diseases in the world, with over 142 million p
125 attractive therapeutic targets for neglected parasitic diseases, including African trypanosomiasis ca
130 ers, cardiovascular diseases, infectious and parasitic diseases, injuries, neuropsychiatric condition
131 ers, cardiovascular diseases, infectious and parasitic diseases, injuries, neuropsychiatric condition
132 nts admitted to hospital with infectious and parasitic diseases (international classification of dise
139 ectrum anthelmintic drug used to treat human parasitic diseases like river blindness and lymphatic fi
141 ems (n = 77 [14.6%]), certain infections and parasitic diseases (n = 62 [11.8%]), and malignant neopl
142 ble for Chagas disease, a neglected tropical parasitic disease native to the Americas that is current
145 inellosis is a globally important food-borne parasitic disease of humans caused by roundworms of the
146 Giardiasis is the most common intestinal parasitic disease of humans identified in the United Sta
147 ur discussion on malaria, the most important parasitic disease of humans, but also highlight the broa
148 Schistosomiasis is the second most important parasitic disease of public health importance in Africa,
150 tomatic phase of neurocysticercosis (NCC), a parasitic disease of the central nervous system (CNS) in
152 stolytica causes invasive amebiasis, a major parasitic disease of the developing world, whose primary
154 cularis is one of the most severe and lethal parasitic diseases of humans, most often reported in Eur
155 en pan-vaccine for prevention and control of parasitic diseases of medical and veterinary concern.
156 otective immune-mechanisms generated against parasitic diseases of swine, cDNA was generated from a m
159 the treatment of allergic, inflammatory, and parasitic diseases or even malignancies in which IL-13 p
161 nts admitted to hospital with infectious and parasitic diseases (P<0.05), mental and behavioural diso
163 born affected by the mother's infectious and parasitic diseases (PMRc = 7.3), unspecified cerebral pa
164 significance of leishmaniasis as a neglected parasitic disease-ranking second in mortality and fourth
165 ition, income, and resilience in Africa, yet parasitic diseases remain a major constraint to producti
166 s, prevention, and control of infectious and parasitic diseases remains a global priority, as these s
173 RR, 2.00; 95% CI, 1.87-2.14), infectious and parasitic diseases (RR, 1.69; 95% CI, 1.61-1.77), and ma
174 se in West Africa increase the burden of the parasitic disease schistosomiasis by fuelling the growth
176 rtuin inhibitors) targeted to the main human parasitic diseases (schistosomiasis, malaria, trypanosom
177 1 vaccines (the first vaccines for any human parasitic disease), summarizing their benefits and limit
181 ntifies a vaccine candidate for an important parasitic disease that has constrained socioeconomic dev
186 a group of viral, bacterial, and eukaryotic parasitic diseases that are especially endemic in low-in
189 ogress on evaluating the burden of foodborne parasitic diseases that has been generated by this study
190 el effective intervention strategies against parasitic diseases that still pose an alarming threat to
191 Of the insects that serve as vectors for parasitic diseases, the genus Anopheles is the most impo
193 Host nutrition can affect the outcome of parasitic diseases through metabolic effects on host imm
196 nse and Trypanosoma brucei rhodesiense, is a parasitic disease transmitted by the tsetse fly in sub-S
197 orns affected by the mother's infectious and parasitic diseases, unspecified cerebral palsy, and unsp
198 ate the relative effects of vector-borne and parasitic diseases (VBPDs) and income on each other, con
200 ns for inflammation because of infectious or parasitic diseases was recently proposed, especially in
201 that 48% (95% UI 38%-56%) of cases of these parasitic diseases were foodborne, resulting in 76% (95%
203 ld with severe viral, bacterial, fungal, and parasitic diseases, who was homozygous for a loss-of-fun
206 somiasis remains one of the most devastating parasitic diseases worldwide, and the development of gen
207 ogy of malaria, one of the most deadly human parasitic diseases worldwide, is complex, as it is a sys